Resultaterne fra undersøgelsen var ikke konsistente i undergruppen af patienter med dårlig præstations status (WHO PS=2, n=70), hvor total overlevelse og tid til progression var ens for de to grupper.
The results from the trial were not consistent in the subgroup of patients with a poor performance status (WHO PS=2, n=70), where overall survival and time to progression were similar in both arms.